Q1 2024 Taysha Gene Therapies Inc Earnings Call Transcript

May 14, 2024 / 08:30PM GMT
Operator

Greetings and welcome to the Taysha Gene Therapies first quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded It is now my pleasure to introduce your host, Hayleigh Collins. Thank you. You may begin.

Hayleigh Collins - Taysha Gene Therapies Inc - Director, Head of Corporate Communications and Investor Relations

Thank you. Good afternoon, and welcome to Teva's First Quarter 2024 financial results and corporate update conference call. Earlier today, we issued a press release announcing financial results for the first quarter ended March 31, 2024. A copy of this press release is available on the Company's website and through our SEC filings.

Joining me on today's call are Sean Nolan, Taysha's CEO; Sukumar Nagendran, President and Head of R&D; and Kamran Alam, Chief Financial Officer. We will hold a question and answer session following our prepared remarks.

Please note that on today's call, we will be making forward-looking statements, including statements relating to the therapeutic and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot